Related Experiment Video
Updated: Aug 5, 2026

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
The FGFRL1-FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR
Yupeng Chen1, Jiarun Lai2, Jian Chen1
1Department of Urology, School of Medicine, The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, 510180, China.
Abstract:
AR pathway-independent prostate cancer (ARIPC), particularly neuroendocrine prostate cancer (NEPC), represents one of the most lethal states of metastatic castration-resistant prostate cancer. However, how fatty acid synthesis (FAS) is organized in ARIPC and whether distinct lipogenic states shape neuroendocrine lineage transdifferentiation remain unclear. By integrating single-cell and bulk transcriptomic analyses of mCRPC cohorts, we identify NEPC as a fatty-acid-synthesis-low state associated with poor survival. Within this context, fatty acid synthase (FASN) emerges as a key indicator and functional contributor to lipogenic activity. FASN depletion suppresses lipogenesis while increasing NEPC-associated programs, migration, and metastatic colonization. We further identify FGFRL1 as the FGF family member most consistently associated with fatty acid synthesis activity in ARIPC. FGFRL1 depletion reduces FASN expression and relative free fatty-acid content, while targeted GC-MS supports broader fatty-acid remodeling and fluorescent uptake assays show increased exogenous fatty-acid uptake. FASN restoration partially restores relative free fatty-acid content and attenuates NEPC-associated and migratory phenotypes. Directional perturbation, rescue, AKT phosphorylation, and co-immunoprecipitation analyses further support the functional FGFRL1-FASN relationship. ONECUT2 is prioritized as a candidate downstream transcriptional regulator whose expression correlates with the neuroendocrine program. Together, these findings support an FGFRL1-FASN metabolic axis that regulates neuroendocrine lineage transdifferentiation and metastatic progression in ARIPC.
Insights
Neuroendocrine prostate cancer (NEPC) is a low fatty acid synthesis state linked to poor survival. The FGFRL1-FASN metabolic axis regulates NEPC transdifferentiation and metastasis in AR pathway-independent prostate cancer.
Area of Science:
- Oncology
- Metabolic pathways
- Cancer biology
Background:
- AR pathway-independent prostate cancer (ARIPC), especially neuroendocrine prostate cancer (NEPC), is a lethal form of metastatic castration-resistant prostate cancer (mCRPC).
- The role of fatty acid synthesis (FAS) in ARIPC and its influence on neuroendocrine lineage transdifferentiation are not well understood.
Purpose of the Study:
- To investigate the organization of FAS in ARIPC.
- To determine if distinct lipogenic states influence neuroendocrine lineage transdifferentiation.
- To identify key molecular players in this process.
Main Methods:
- Integration of single-cell and bulk transcriptomic analyses of mCRPC cohorts.
- Functional studies involving depletion and restoration of fatty acid synthase (FASN) and FGFRL1.
- Targeted gas chromatography-mass spectrometry (GC-MS) and fluorescent uptake assays.
- Directional perturbation, rescue, AKT phosphorylation, and co-immunoprecipitation analyses.
Main Results:
- NEPC is characterized as a fatty-acid-synthesis-low state associated with poor survival.
- FASN is a key indicator and functional driver of lipogenic activity; its depletion suppresses lipogenesis but enhances NEPC programs and metastasis.
- FGFRL1 is identified as a key regulator of FAS in ARIPC, influencing FASN expression and fatty acid content.
- The FGFRL1-FASN axis was functionally validated, and ONECUT2 was identified as a downstream regulator.
Conclusions:
- An FGFRL1-FASN metabolic axis plays a crucial role in regulating neuroendocrine lineage transdifferentiation.
- This axis is implicated in the metastatic progression of AR pathway-independent prostate cancer.
- Targeting this metabolic pathway may offer therapeutic strategies for aggressive prostate cancer.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
